270 related articles for article (PubMed ID: 28196644)
1. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
Przybyszewska J; Zlotogorski A; Ramot Y
J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
[TBL] [Abstract][Full Text] [Related]
2. A novel approach to the classification of epidermodysplasia verruciformis.
Huang S; Wu JH; Lewis DJ; Rady PL; Tyring SK
Int J Dermatol; 2018 Nov; 57(11):1344-1350. PubMed ID: 30156265
[TBL] [Abstract][Full Text] [Related]
3. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
[TBL] [Abstract][Full Text] [Related]
4. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
5. Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease.
Imahorn E; Yüksel Z; Spoerri I; Gürel G; Imhof C; Saraçoğlu ZN; Koku Aksu AE; Rady PL; Tyring SK; Kempf W; Itin PH; Burger B
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1722-1726. PubMed ID: 28646613
[TBL] [Abstract][Full Text] [Related]
6. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
McDermott DF; Gammon B; Snijders PJ; Mbata I; Phifer B; Howland Hartley A; Lee CC; Murphy PM; Hwang ST
Pediatr Dermatol; 2009; 26(3):306-10. PubMed ID: 19706093
[TBL] [Abstract][Full Text] [Related]
7. Epidermodysplasia verruciformis in lipoid proteinosis: case report and discussion of pathophysiology.
O'Blenes C; Pasternak S; Issekutz A; Gillis J; Chowdhury D; Finlayson L
Pediatr Dermatol; 2015; 32(1):118-21. PubMed ID: 23534907
[TBL] [Abstract][Full Text] [Related]
8. Epidermodysplasia verruciformis.
Burger B; Itin PH
Curr Probl Dermatol; 2014; 45():123-31. PubMed ID: 24643182
[TBL] [Abstract][Full Text] [Related]
9. Identification of LCK mutation in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma.
Li SL; Duo LN; Wang HJ; Dai W; Zhou EH; Xu YN; Zhao T; Xiao YY; Xia L; Yang ZH; Zheng LT; Hu YY; Lin ZM; Wang HN; Gao TW; Ma CL; Yang Y; Li CY
Br J Dermatol; 2016 Dec; 175(6):1204-1209. PubMed ID: 27087313
[TBL] [Abstract][Full Text] [Related]
10. [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model].
Orth G
Bull Acad Natl Med; 2010 Jun; 194(6):923-40; discussion 941. PubMed ID: 21513129
[TBL] [Abstract][Full Text] [Related]
11. Homozygosity for the c.917A→T (p.N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz.
Arnold AW; Burger B; Kump E; Rufle A; Tyring SK; Kempf W; Häusermann P; Itin PH
Dermatology; 2011 Feb; 222(1):81-6. PubMed ID: 21196704
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in
Torres AD; King RE; Uberoi A; Buehler D; Yoshida S; Ward-Shaw E; Lambert PF
J Virol; 2024 Jun; ():e0017424. PubMed ID: 38869286
[TBL] [Abstract][Full Text] [Related]
13. Multiple flat-topped scaly violaceous papules.
Girijala RL; Nyinawinyange D; Parekh PK; Grimwood RE
Dermatol Online J; 2019 Mar; 25(3):. PubMed ID: 30982308
[TBL] [Abstract][Full Text] [Related]
14. Acquired epidermodysplasia verruciformis.
Rogers HD; Macgregor JL; Nord KM; Tyring S; Rady P; Engler DE; Grossman ME
J Am Acad Dermatol; 2009 Feb; 60(2):315-20. PubMed ID: 19150275
[TBL] [Abstract][Full Text] [Related]
15. The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.
Horton JS; Stokes AJ
Oncoimmunology; 2014 Jan; 3(1):e28288. PubMed ID: 24800179
[No Abstract] [Full Text] [Related]
16. Epidermodysplasia verruciformis: report of two patients with autosomal dominant inheritance.
Miotto IZ; De Oliveira WRP
Dermatol Online J; 2021 Feb; 27(2):. PubMed ID: 33818984
[TBL] [Abstract][Full Text] [Related]
17. Epidermodysplasia verruciformis associated with HPV 10.
Zahir A; Craig L; Rady P; Tyring S; Ehrlich A
Dermatol Online J; 2013 Apr; 19(4):2. PubMed ID: 24021362
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
Liang S; Zuo YG; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
[TBL] [Abstract][Full Text] [Related]
19. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
Berthelot C; Dickerson MC; Rady P; He Q; Niroomand F; Tyring SK; Pandya AG
J Am Acad Dermatol; 2007 May; 56(5):882-6. PubMed ID: 17368633
[TBL] [Abstract][Full Text] [Related]
20. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.
Crequer A; Troeger A; Patin E; Ma CS; Picard C; Pedergnana V; Fieschi C; Lim A; Abhyankar A; Gineau L; Mueller-Fleckenstein I; Schmidt M; Taieb A; Krueger J; Abel L; Tangye SG; Orth G; Williams DA; Casanova JL; Jouanguy E
J Clin Invest; 2012 Sep; 122(9):3239-47. PubMed ID: 22850876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
